Five-year retrospective review of end-of-life care quality metrics in a large, multidisciplinary community oncology practice.

Authors

null

Angela Kalisiak

Compass Oncology, Portland, OR

Angela Kalisiak, Elizabeth Ann Gandara, Susan C Hedlund, Justin K Gress

Organizations

Compass Oncology, Portland, OR, Compass Oncology, Millwaukie, OR, Compass Consultant, Professor, Portland State University, Portland, OR

Research Funding

No funding sources reported

Background: It is increasingly recognized that earlier integration of palliative care for patients with advanced cancers positively impacts both cost and quality of oncology care. Compass Oncology (CO) is a multidisciplinary community oncology practice and a member of The US Oncology Network; 39 medical, gynecologic, and radiation oncologists and 18 advance practice providers serve patients at 6 sites in Oregon and Washington. In 2008, CO prioritized practice improvement in end of life care, identifying metrics for ongoing assessment. Between 2009 and 2014, quality improvement (QI) projects focused on communication skills; whole-staff palliative care education; integration of social workers; initiation of embedded palliative care at 2 sites; and development of a more standardized approach to Advance Care Planning (ACP). Methods: Systematic retrospective record review of patient deaths from January 2009 to December 2013, targeting analysis of hospice utilization, chemotherapy use at end of life, and ACP. Results: Among patients with a CO visit within 6 months of a documented date of death (n= 783 in 2009; n= 909 in 2013), both hospice utilization and ACP participation improved significantly. Percent of patients with evidence for Advance Directive (AD), POLST or code status documented in the electronic medical record (EMR) improved from 36% in 2009 to 50 % in 2013 (p<0.001). Percent of patients enrolled in hospice at the time of death improved from 56% in 2009 to 63% in 2013 (p= 0.003). No statistically significant change was noted in % patients receiving chemotherapy in the last 14 days of life. Conclusions: Focused implementation of end of life care QI strategies in a large multidisciplinary community oncology practice appears to result in both improved hospice utilization and ACP. Chemotherapy usage in the last 14 days of life remains a meaningful target for intervention. Future QI efforts will focus on ongoing, scalable improvement in these metrics.

Metrics 2009 2010 2011 2012 2013
% Patients enrolled in hospice 56.1 59.2 63.5 61.5 62.7
% Patients with AD/POLST/code status in EMR 36.4 40.0 41.6 40.3 49.6
% Patients receiving chemotherapy in last 14 days of life 9.5 12.7 12.2 12.9 9.0

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 Palliative and Supportive Care in Oncology Symposium

Session Type

Poster Session

Session Title

General Poster Session A: End-of-Life Care, <span>Patient-Reported Outcomes</span>, and Survivorship

Track

Survivorship,Patient-Reported Outcomes: Mechanisms of Symptoms and Treatment Toxicities,Early Integration of Palliative Care in Cancer Care,Psycho-oncology,End-of-Life Care

Sub Track

End-of-Life Care

Citation

J Clin Oncol 32, 2014 (suppl 31; abstr 108)

DOI

10.1200/jco.2014.32.31_suppl.108

Abstract #

108

Poster Bd #

B5

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Annual Meeting

The impact of end-of-life quality metrics on date of death and hospice documentation over time.

First Author: Divya Deepak

Abstract

2024 ASCO Quality Care Symposium

Impact of a mortality prediction tool on end-of-life (EOL) quality measures.

First Author: Jody S. Garey